Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
An FDA panel is recommending a new treatment option for peanut allergy that helps reduce the risk of severe reactions in case of accidental exposure. Dr. Kari Nadeau, director of the Sean N. Parker Center for Allergy and Asthma Research, Dr. Sharon Chinthrajah, clinical associate professor of medicine, andDr. Tina Sindher, clinical assistant professor of medicine, provide comment on the findings and the benefits of the new treatment option.